Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 09 October 2012 | By Alexander Gaffney, RAC
Australia's Therapeutic Goods Administration (TGA) is preparing to establish procedures, guidelines and a timetable for the implementation of the submission of medicine applications using the electronic Common Technical Document (eCTD), it announced on 9 October.
The eCTD is an electronic, module-based regulatory application format developed and maintained by the International Conference on Harmonisation (ICH). The basic premise of the eCTD is to harmonize the layout and format of pharmaceutical submission documents to the extent possible to allow for easier and faster filing and reviews of applications.
The eCTD format has already been adopted by some of the world's largest regulatory bodies, including the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) and Japan's Ministry of Health, Labor and Welfare (MHLW).
TGA said it intends to work closely with the pharmaceutical industry to establish an eCTD framework in Australia, as well as a timetable for the transition.
Current applications to TGA are submitted in both paper and electronic format, which TGA acknowledged is costly and difficult to process. Though the electronic forms allow for somewhat easier processing, the hard copy submitted to TGA is deemed to be the, "Authoritative source of data supporting a regulatory application."
Tags: Timetable, Guidelines, electronic, Latest News, pharmaceutical, eCTD, australia, drug
Regulatory Focus newsletters
All the biggest regulatory news and happenings.